David R. Anderson

31.3k total citations · 9 hit papers
271 papers, 19.2k citations indexed

About

David R. Anderson is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, David R. Anderson has authored 271 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Internal Medicine, 97 papers in Cardiology and Cardiovascular Medicine and 73 papers in Surgery. Recurrent topics in David R. Anderson's work include Venous Thromboembolism Diagnosis and Management (136 papers), Atrial Fibrillation Management and Outcomes (68 papers) and Central Venous Catheters and Hemodialysis (29 papers). David R. Anderson is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (136 papers), Atrial Fibrillation Management and Outcomes (68 papers) and Central Venous Catheters and Hemodialysis (29 papers). David R. Anderson collaborates with scholars based in Canada, United States and United Kingdom. David R. Anderson's co-authors include Marc Rodger, Michael J. Kovacs, Philip S. Wells, Clive Kearon, George Kovács, Susan R. Kahn, Melissa Forgie, J. Hirsh, Michael Mitchell and David Barnes and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

David R. Anderson

260 papers receiving 18.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

2001 1.2k citations David R. Anderson et al. profile →
Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis

2003 990 citations Philip S. Wells, David R. Anderson et al. New England Journal of Medicine profile →
Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d-dimer

2001 934 citations Philip S. Wells, David R. Anderson et al. Annals of Internal Medicine profile →
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis

1996 872 citations Michael Gent, David R. Anderson et al. New England Journal of Medicine profile →
Value of assessment of pretest probability of deep-vein thrombosis in clinical management

1997 764 citations Philip S. Wells, David R. Anderson et al. profile →
Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism

1998 650 citations P. S. Wells, David R. Anderson et al. Annals of Internal Medicine profile →
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome

2003 591 citations Mark Crowther, Jim A. Julian et al. New England Journal of Medicine profile →
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

2003 544 citations Clive Kearon, Jeffrey S. Ginsberg et al. New England Journal of Medicine profile →
Accuracy of clinical assessment of deep-vein thrombosis

1995 514 citations David R. Anderson, Clive Kearon et al. profile →

Peers

Countries citing papers authored by David R. Anderson

Since Specialization

Citations

This map shows the geographic impact of David R. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Anderson more than expected).

Fields of papers citing papers by David R. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Anderson. The network helps show where David R. Anderson may publish in the future.

Co-authorship network of co-authors of David R. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Anderson. A scholar is included among the top collaborators of David R. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Anderson. David R. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism 2023 ·Journal of Thrombosis and Haemostasis ·Lucia Caiano, Michael J. Kovacs, Alejandro Lazo‐Langner, David R. Anderson, Susan R. Kahn, Vinay Shah, Scott Kaatz, (unknown), Sam Schulman, Isabelle Chagnon, Ranjeeta Mallick, Marc Rodger, Philip S. Wells	3
2	Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study 2021 ·Journal of Thrombosis and Haemostasis ·(unknown), Leslie Skeith, Marc Rodger, Elham Sabri, Marc Righini, Michael J. Kovacs, Marc Carrier, Susan R. Kahn, Philip S. Wells, David R. Anderson, Isabelle Chagnon, Susan Solymoss, Mark Crowther, Richard H. White, Grégoire Le Gal	6
3	Physical Activity Surveillance in the United States for Work and Commuting 2021 ·Journal of Occupational and Environmental Medicine ·Laurie P. Whitsel, (unknown), David R. Anderson, Alan M. Beck, Cedric X. Bryant, (unknown), Russell L. Carson, Anne L. Escaron, (unknown), Mary T. Imboden, (unknown), Nicolaas P. Pronk, Janet R. Wojcik, (unknown), Elizabeth Ablah	5
4	Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode 2017 ·Journal of Thrombosis and Haemostasis ·(unknown), Marc Carrier, Judy Kovacs, Marc Rodger, M.J. Kovacs, Grégoire Le Gal, Philip S. Wells, Tim Ramsay, Susan R. Kahn, Isabelle Chagnon, Susan Solymoss, David R. Anderson, Mark Crowther, R. White	2
5	Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study 2016 ·Blood ·Alejandro Lazo‐Langner, Susan R. Kahn, Philip S. Wells, David R. Anderson, Marc Rodger, Marc Carrier, (unknown), Judy Kovacs, (unknown), Michael J. Kovacs	3
6	Cardiac hydatid disease in the third world 2011 ·BMJ Case Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), David R. Anderson, Robert Tulloh	2
7	Exposure to Concentrated Ambient Particles Does Not Affect Vascular Function in Patients with Coronary Heart Disease 2008 ·Environmental Health Perspectives ·Nicholas L. Mills, Simon D. Robinson, Paul Fokkens, Daan L. A. C. Leseman, Mark R. Miller, David R. Anderson, Evelyn Freney, Mathew R. Heal, Robert J. Donovan, Anders Blomberg, Thomas Sandström, William MacNee, Nicholas A. Boon, Ken Donaldson, David E. Newby, Flemming R. Cassee	90
8	The Use of Leg Venous Ultrasonography for the Diagnosis of Pulmonary Embolism 2008 ·Seminars in Nuclear Medicine ·David R. Anderson, David Barnes	8
9	D‐dimer testing is useful to exclude deep vein thrombosis in elderly outpatients 2008 ·Journal of Thrombosis and Haemostasis ·Marc Carrier, Grégoire Le Gal, Shannon M. Bates, David R. Anderson, P. S. Wells	22
10	Arterial Stiffness is Independently Associated with Emphysema Severity in Patients with Chronic Obstructive Pulmonary Disease 2007 ·American Journal of Respiratory and Critical Care Medicine ·David McAllister, John D. Maclay, Nicholas L. Mills, Grant Mair, (unknown), David R. Anderson, David E. Newby, John T. Murchison, William MacNee	214
11	The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty 2007 ·Journal of Bone and Joint Surgery ·Chris Skedgel, Ron Goeree, (unknown), Kara Thompson, Bernie J. OʼBrien, David R. Anderson	28
12	An Evaluation of D-Dimer in the Diagnosis of Pulmonary Embolism 2006 ·Annals of Internal Medicine ·Clive Kearon, Jeffrey S. Ginsberg, James D. Douketis, Alexander G.G. Turpie, Shannon M. Bates, Agnes Y. Lee, Mark Crowther, Jeffrey I. Weitz, Patrick Brill-Edwards, Philip Wells, David R. Anderson, Michael J. Kovacs, Lori‐Ann Linkins, Jim A. Julian, (unknown), Michael Gent	7
13	Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis 2005 ·Journal of Thrombosis and Haemostasis ·Susan R. Kahn, Clive Kearon, J.A. Julian, Betsy MacKinnon, M.J. Kovacs, Philip Wells, Mark Crowther, David R. Anderson, (unknown), C. Demers, Susan Solymoss, Jeannine Kassis, William Geerts, Marc Rodger, J. Hambleton, Jeffrey S. Ginsberg	147
14	Anticoagulation in atrial fibrillation. Is there a gap in care for ambulatory patients? 2004 ·PubMed ·Wayne Putnam, (unknown), David R. Anderson, (unknown), (unknown), Fred Burge, Gordon Flowerdew, Jafna L. Cox	3
15	A Pilot Study Evaluating the Feasibility of Monitoring Oral Anticoagulant Therapy with Point-of-Care Testing in a Community Pharmacy 2004 ·The Canadian Journal of Hospital Pharmacy ·Jo‐Anne Wilson, (unknown), Jafna L. Cox, (unknown), (unknown), (unknown), (unknown), David R. Anderson	6
16	A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism 2003 ·Thrombosis Research ·Sheila Sprague, (unknown), David R. Anderson, Bernie J. OʼBrien	3
17	Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis breakdown → 2003 ·New England Journal of Medicine ·Philip S. Wells, David R. Anderson, Marc Rodger, Melissa Forgie, Clive Kearon, Jonathan Dreyer, George Kovács, Michael Mitchell, Bernard Lewandowski, Michael J. Kovacs	990
18	A Model for Perioperative Outpatient Management of Anticoagulation in High-Risk Patients: An Evaluation of Effectiveness and Safety 2001 ·The Canadian Journal of Hospital Pharmacy ·Jo‐Anne Wilson, Jennifer Morgan, Lisa Gray, (unknown), David R. Anderson	14
19	Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy 2001 ·The American Journal of Medicine ·(unknown), Philip S. Wells, David R. Anderson, Michael J. Kovacs	67
20	A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process 1998 ·Journal of Internal Medicine ·Wells, (unknown), David R. Anderson, (unknown), Foster, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact